CHRISTINA CHRISTENSEN: Open Payments
NPI 1114680311 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,241 in 278 payments from 22 companies in 2025. Trend: 2023 $2,980 · 2024 $4,356 · 2025 $5,241
Food & beverage: $5,142Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 67 | $1,204 |
| Janssen Biotech, Inc. | 33 | $803 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 59 | $662 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $454 |
| QOL Medical, LLC | 16 | $333 |
| VIVUS LLC | 16 | $322 |
| Aimmune Therapeutics, Inc. | 12 | $310 |
| Amgen Inc. | 7 | $141 |
| PFIZER INC. | 7 | $138 |
| Lilly USA, LLC | 7 | $138 |
Products named: TREMFYA, XIFAXAN, RINVOQ, ENTYVIO, Sucraid, SKYRIZI, PANCREAZE, ZENPEP.
Industry payments across NC — which companies pay providers there.
